Overall, approximately 80% of patients diagnosed with ovarian epithelial cancer will relapse after first-line platinum-based and taxane-based chemotherapy and may benefit from subsequent therapies. Early detection of persistent disease by second-look laparotomies after completing first-line treatment is no longer practiced; when the outcomes in the 50% of institutions practicing such procedures were informally compared with the outcomes in those institutions not using such procedures, additional...
This link will take you to the Lance Armstrong Foundation's web site. Click
on "Hear from others" and then select "Ovarian" under
"Search for Stories" for personal stories from ovarian cancer